Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study

Quality of life (QOL) must be carefully monitored in older patients with lymphoma who are suitable for chemotherapy, but few reports have assessed QOL in older patients who received reduced-intensity chemotherapy. This study investigated QOL in patients with lymphoma aged ≥80 years to clarify the fe...

Full description

Bibliographic Details
Main Author: Satoshi Yamasaki
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Hematology Reports
Subjects:
Online Access:https://www.mdpi.com/2038-8330/16/1/1